We a good story
Quick delivery in the UK

NRF2 as a Central Point in Cancer Metastasis

About NRF2 as a Central Point in Cancer Metastasis

NRF2 is a master regulator of the anti-oxidative stress response through controlling the expression of anti-oxidative stress response proteins and detoxifying enzymes. Cancer cells also exploit NRF2 protective functions to thrive and resist anti-tumor drugs. NRF2 is highly active in several types of human cancers and is associated with aggressiveness and metastasis. NRF2 affects many targets that are involved in hypoxia, angiogenesis, invasion, drug resistance, and epithelial-mesenchymal transition. NRF2 was found to be targeted by many microRNAs, so that it could be used as effective cancer therapy to improve the outcomes and contribute to the advancement of anti-tumor drugs.

Show more
  • Language:
  • English
  • ISBN:
  • 9786139967148
  • Binding:
  • Paperback
  • Pages:
  • 60
  • Published:
  • December 9, 2018
  • Dimensions:
  • 229x152x4 mm.
  • Weight:
  • 100 g.
Delivery: 1-2 weeks
Expected delivery: May 5, 2025

Description of NRF2 as a Central Point in Cancer Metastasis

NRF2 is a master regulator of the anti-oxidative stress response through controlling the expression of anti-oxidative stress response proteins and detoxifying enzymes. Cancer cells also exploit NRF2 protective functions to thrive and resist anti-tumor drugs. NRF2 is highly active in several types of human cancers and is associated with aggressiveness and metastasis. NRF2 affects many targets that are involved in hypoxia, angiogenesis, invasion, drug resistance, and epithelial-mesenchymal transition. NRF2 was found to be targeted by many microRNAs, so that it could be used as effective cancer therapy to improve the outcomes and contribute to the advancement of anti-tumor drugs.

User ratings of NRF2 as a Central Point in Cancer Metastasis



Join thousands of book lovers

Sign up to our newsletter and receive discounts and inspiration for your next reading experience.